Did you know? Labour pain relieving drug may cut need for epidural

Prescribing women a new drug called remifentanil to help manage their labour pain may halve the need for an epidural than the traditional pethidine, claims a study.

By: Agencies | | Published: August 14, 2018 7:58 pm

Tags: Child labour Labour & delivery Pregnant women Women women issue

Inducing labour might not increase chances of c-section. © Shutterstock

The study, published in the Lancet, suggested that using remifentanil instead of pethidine could reduce the need for epidurals, instrumental deliveries and consequent morbidity for large numbers of women worldwide.

Related Stories

Epidurals — injections of pain relief drugs around the spinal cord — provide effective pain relief but increase the risk of needing instrumental delivery (forceps or vacuum) during birth.

It can also increase the risk of trauma and long-lasting problems for the mother, such as incontinence and sexual dysfunction.

“Our findings challenge the routine use of pethidine for pain relief during labour,” said lead author Matthew Wilson, from Britain’s University of Sheffield.

“Remifentanil reduced the need for an epidural by half and there were no lasting problems for the mothers and babies in our trial, although the effect of remifentanil on maternal oxygen levels needs to be clarified in further studies,” he added.

Remifentanil is rarely offered routinely in labour and its use restricted to women who cannot receive an epidural for medical reasons (such as blood clotting disorders).

Conversely, pethidine has been in widespread use since the 1950s, even after long been known not helpful to all women.

The study included 400 women aged over 16 years old who were giving birth after 37 weeks.

Only half as many women in the remifentanil group went on to have an epidural (19 per cent) than in the pethidine group (41 per cent).

These women rated their pain as less severe and also had less likely to need forceps and vacuum during labour than women given pethidine (15 per cent vs 26 per cent).

However, remifentanil was associated with twice as many mothers having low oxygen levels than pethidine (14 per cent vs 5 per cent.

But, despite this increase it did not cause any negative effects for the mother or baby, but more research in larger groups will be needed to confirm this, the researchers said.

Source: IANS

Image Source: Shutterstock

Published : August 14, 2018 7:58 pm

Read Disclaimer

Long-term vaping may damage lung immune cells, says study

Long-term vaping may damage lung immune cells, says study

Cycling can reduce your loneliness, boost mental health, says study

Cycling can reduce your loneliness, boost mental health, says study

About The health Site

TheHealthSite.com is India's largest health site with more than 40 lakh unique visitors per month. We focus on fitness, beauty, health, pregnancy and more.

Most popular health and wellness website in India in 2012 at the Website of the year awards.

health@corp.india.com

+91 – 22 – 6697 1234

91 – 22 – 2490 0302.

ZEE ENTERTAINMENT ENTERPRISES LTD, 18th floor, A-Wing, Marathon Futurex, N. M. Joshi Marg, Lower Parel, Mumbai, Maharashtra 400013.

We respect your privacy

Copyright © 2020 Zee Entertainment Enterprises Limited. All rights reserved.